Boardroom Radio - Straight from the source

Australia's Largest Corporate Webcaster

"Boardroom Radio brings companies to my desk. I can hear more investor briefings. Also the calendar is very useful" Matt Williams, Portfolio Manager, Perpetual

"IRESS is always seeking innovative ways to deliver relevant content to our professional user base. Webcasting is a growing and increasingly important way to communicate and we are very pleased to team with Boardroom Radio to further expand our company disclosure information." Peter Dunai, Managing Director, IRESS

"As the investment world continues to become more virtual and the reaction to the release of new investment information becomes faster, Boardroom Radio offers an easy way for all investors to access the latest information for companies." Peter Morgan, Founder 452 Capital

"Boardroom Radio will be a valuable tool to help us manage our time and connect with companies whose stories we wouldn’t normally hear" Ben Griffiths, Eley Griffiths Group

"The service from Boardroom Radio has been outstanding. To hear that we had so many listeners confirmed that Boardroom Radio is an effective communication tool." Roc Oil (ROC)

"Macquarie Airports is happy to trial new and innovative ways of increasing communication to our investors. Boardroom Radio is a particularly easy and flexible method of informing all our stakeholders of MAp's activities." Macquarie Airports (MAP)

"Boardroom Radio provides a modern, highly effective means of communicating Bonaparte's key developments to its shareholders and to a broader spectrum of the investing community in a concise and personal way." Bonaparte Diamond Mines NL

TISSUE THERAPIES LIMITED (TIS)

ASX code: TIS
Listing Date: Fri, 19 Mar 2004
Website: http://www.tissuetherapies.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
Developing biomedical technologies for wound healing and tissue and cell culture.

Address:
66 Eagle Street, Central Plaza Two, Level 11
BRISBANE
QLD 4000

Phone: (07) 3839 9938
Fax: (07) 3839 1486

Executives & Directors

Mr Roger Clarke, Chairman
Dr Steven Mercer, Director, CEO
Mr Gregory Baynton, Director
Prof. David Gardiner, Director
Mr Don Home, Non Exec. Director
Mr Drummond McKenzie, Company Secretary

Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for TIS

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

View this company's details on the Australian Securities Exchange website

TISSUE THERAPIES LIMITED (TIS) Events

Company (Stock Code)	Date/Time	Event
TISSUE THERAPIES LIMITED (TIS)	Mon, 27 Mar 2006 02:30PM	TIS - Small Caps Forum Interview with Dr Steven Mercer, CEO
TISSUE THERAPIES LIMITED (TIS)	Thu, 26 Feb 2009 11:00PM	Interim Results
TISSUE THERAPIES LIMITED (TIS)	Thu, 27 Nov 2008 10:30AM 10:30AM Australia/Queensland	Annual General Meeting McCullough Robertson Lawyers, Level 11, Central Plaza 2, 66 Eagle St, Brisbane, QLD
TISSUE THERAPIES LIMITED (TIS)	Mon, 18 Aug 2008	Full Year Results
TISSUE THERAPIES LIMITED (TIS)	Thu, 18 Oct 2007 10:30AM	Annual General Meeting Queensland University of Technology, corner of Musk Avenue and Blamey Street Kelvin Grove QLD 4059
TISSUE THERAPIES LIMITED (TIS)	Thu, 9 Aug 2007	Full Year Results
TISSUE THERAPIES LIMITED (TIS)	Wed, 7 Feb 2007 11:00PM	Interim Results
TISSUE THERAPIES LIMITED (TIS)	Thu, 9 Nov 2006 11:00AM	Annual General Meeting Queensland University of Technology, Cnr Musk Avenue and Blamey Street Kelvin Grove QLD 4059
TISSUE THERAPIES LIMITED (TIS)	Thu, 3 Aug 2006	Full Year Results
TISSUE THERAPIES LIMITED (TIS)	Wed, 8 Feb 2006 11:00PM	Interim Results
TISSUE THERAPIES LIMITED (TIS)	Fri, 11 Nov 2005 10:15AM 10:15AM Australia/Queensland	Annual General Meeting
		Display

TISSUE THERAPIES LIMITED (TIS)

Click here to view details on the ASX site

More VitroGro Patents Granted in South Korea and Australia	Wed, 1 Jul 2009
Dr Cherrell Hirst Appointed Director	Tue, 30 Jun 2009
Results of 2nd Patient in Canadian Clinical Trial	Wed, 29 Apr 2009
Appendix 4C - quarterly report	Wed, 29 Apr 2009
Resignation of Professor David Gardiner as Director	Tue, 14 Apr 2009
Change in substantial holding	Mon, 30 Mar 2009
Appendix 3B	Thu, 19 Mar 2009
Appointment of Mel Bridges as Company Director	Fri, 13 Mar 2009
Change of Directors` Interests Following Rights Issue	Thu, 12 Mar 2009
Appendix 3B Further Investment in Tissue Therapies	Tue, 10 Mar 2009

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.